Company: REVB
Filing Date: 2025-09-16
Form Type: S-3
Source: 0001193125-25-205145
Chunk: 9

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-09-16
Form: S-3
Chunk 9
---
ucement Letter, the form of which is attached as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on September 15, 2025, and is incorporated herein by reference.

<div align='center'>6</div>

SELLING STOCKHOLDERS The 13,065,000 shares of common stock being offered by the Selling Stockholders, are the shares of common stock underlining the Class I Common Stock Warrants, issued by the Company to the Selling Stockholders as part of the Inducement Letter which was signed on September 10, 2025. For additional information regarding the issuance of the securities, see “ Private Placement of Warrants” above. We are registering the shares of common stock in order to permit the Selling Stockholders to offer the shares for resale from time to time. Except as otherwise described in the footnotes to the table below, neither the Selling Stockholders nor any of the persons that control them has had any material relationships with us or our affiliates within the past three (3) years. The number of shares and percentages of beneficial ownership set forth below are based on 2,339,306 shares of our common stock outstanding as of September 11, 2025. The table below lists the Selling Stockholders and other information regarding the beneficial ownership as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended (and the rules and regulations thereunder) of the shares of common stock held by the Selling Stockholders. The second column lists the number of shares of common stock beneficially owned by each Selling Stockholder before this offering (including shares which the Selling Stockholder has the right to acquire within 60 days, including upon conversion of any convertible securities). The third column lists the shares of common stock being offered by this prospectus by each Selling Stockholder. The fourth and fifth columns list the number of shares of common stock beneficially owned by each Selling Stockholder and their percentage ownership after the offering (including shares which the Selling Stockholder has the right to acquire within 60 days, including upon conversion of any convertible securities), assuming the sale of all of the shares offered by each Selling Stockholder pursuant to this prospectus.

| Selling Stockholder                           |     | Number of Shares Owned Before Offering(1) | Shares Offered Hereby | Number of Shares Owned After Offering(2) | Percentage of Shares Beneficially Owned After Offering (1)(2) |
| Armistice Capital Master Fund Ltd.(3